A phase 1 and pharmacodynamic study of decitabine in combination with carboplatin in patients with recurrent, platinum-resistant, epithelial ovarian cancer (Q34091420)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	A phase 1 and pharmacodynamic study of decitabine in combination with carboplatin in patients with recurrent, platinum-resistant, epithelial ovarian cancer	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20564122%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

A phase 1 and pharmacodynamic study of decitabine in combination with carboplatin in patients with recurrent, platinum-resistant, epithelial ovarian cancer (English)

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20564122%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

pharmacodynamics

1 reference

based on heuristic

inferred from title

Daniela E. Matei

11

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20564122%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

2

object named as

Curt Balch

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20564122%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Jeanne M. Schilder

3

object named as

Jeanne Schilder

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20564122%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Kenneth P Nephew

10

object named as

Kenneth P Nephew

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20564122%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

author name string

Fang Fang

1

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20564122%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Timothy Breen

4

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20564122%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Shu Zhang

5

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20564122%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Changyu Shen

6

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20564122%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Lang Li

7

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20564122%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Carol Kulesavage

8

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20564122%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Anthony J Snyder

9

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20564122%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

language of work or name

0 references

publication date

1 September 2010

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20564122%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20564122%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

116

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20564122%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

17

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20564122%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

4043-4053

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20564122%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Methylation and protein expression of DNA repair genes: association with chemotherapy exposure and survival in sporadic ovarian and peritoneal carcinomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930033

5 July 2018

Beyond chemotherapy: targeted therapies in ovarian cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930033

5 July 2018

Azacitidine enhances sensitivity of platinum-resistant ovarian cancer cells to carboplatin through induction of apoptosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930033

5 July 2018

DNA methylation: its role in cancer development and therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930033

5 July 2018

DNA methylation changes in ovarian cancer are cumulative with disease progression and identify tumor stage

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930033

5 July 2018

Identification and characterization of ovarian cancer-initiating cells from primary human tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930033

5 July 2018

Modes of action of the DNA methyltransferase inhibitors azacytidine and decitabine.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930033

5 July 2018

Evolution of decitabine development: accomplishments, ongoing investigations, and future strategies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930033

5 July 2018

DNA methylation changes in ovarian cancer: implications for early diagnosis, prognosis and treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930033

5 July 2018

Induction of hypomethylation and molecular response after decitabine therapy in patients with chronic myelomonocytic leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930033

5 July 2018

The management of recurrent ovarian cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930033

5 July 2018

Abnormal DNA methylation, epigenetics, and prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930033

5 July 2018

Mechanisms of resistance to cisplatin and carboplatin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930033

5 July 2018

The epigenomics of cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930033

5 July 2018

Results of a randomized study of 3 schedules of low-dose decitabine in higher-risk myelodysplastic syndrome and chronic myelomonocytic leukemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930033

5 July 2018

Mismatch repair and treatment resistance in ovarian cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930033

5 July 2018

Predictive utility of circulating methylated DNA in serum of melanoma patients receiving biochemotherapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930033

5 July 2018

Analysis of repetitive element DNA methylation by MethyLight

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930033

5 July 2018

DNA methyltransferase inhibitors and the development of epigenetic cancer therapies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930033

5 July 2018

Antimitogenic and chemosensitizing effects of the methylation inhibitor zebularine in ovarian cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930033

5 July 2018

Tumour stem cells and drug resistance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930033

5 July 2018

New anti-cancer strategies: epigenetic therapies and biomarkers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930033

5 July 2018

The epigenetics of ovarian cancer drug resistance and resensitization

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930033

5 July 2018

5-aza-2'-deoxycytidine upregulates caspase-9 expression cooperating with p53-induced apoptosis in human lung cancer cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930033

5 July 2018

Ovarian cancer: strategies for overcoming resistance to chemotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930033

5 July 2018

First-line treatment for advanced ovarian cancer: paclitaxel, platinum and the evidence

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930033

5 July 2018

Plasma nucleic acids in the diagnosis and management of malignant disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930033

5 July 2018

A phase I trial of cisplatin plus decitabine, a new DNA-hypomethylating agent, in patients with advanced solid tumors and a follow-up early phase II evaluation in patients with inoperable non-small cell lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930033

5 July 2018

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930033

5 July 2018

Synergistic cytotoxicity using 2'-deoxy-5-azacytidine and cisplatin or 4-hydroperoxycyclophosphamide with human tumor cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930033

5 July 2018

Tumor Cell-SpecificBRCA1andRASSF1AHypermethylation in Serum, Plasma, and Peritoneal Fluid from Ovarian Cancer Patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25204

21 January 2018

Phase II trial of cisplatin plus decitabine, a new DNA hypomethylating agent, in patients with advanced squamous cell carcinoma of the cervix

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25204

21 January 2018

Phase I and pharmacodynamic trial of the DNA methyltransferase inhibitor decitabine and carboplatin in solid tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25204

21 January 2018

An epigenetic marker panel for screening and prognostic prediction of ovarian cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25204

21 January 2018

Some notable properties of the standard oncology Phase I design.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25204

21 January 2018

Analysis of the pattern of hypersensitivity reactions in patients receiving carboplatin retreatment for recurrent ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25204

21 January 2018

Hypersensitivity reactions to carboplatin administration are common but not always severe: a 10-year experience

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25204

21 January 2018

Quantitative detection of promoter hypermethylation of multiple genes in the tumor, urine, and serum DNA of patients with renal cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25204

21 January 2018

Combining epigenetic and cytotoxic therapy in the treatment of solid tumors.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25204

21 January 2018

Epigenetic patterns in the progression of esophageal adenocarcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930033

28 October 2018

Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2930033

28 October 2018

Reversal of drug resistance in human tumor xenografts by 2'-deoxy-5-azacytidine-induced demethylation of the hMLH1 gene promoter

1 reference

https://pubmed.ncbi.nlm.nih.gov/20564122

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HOXA11 DNA methylation--a novel prognostic biomarker in ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20564122

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Methylation microarray analysis of late-stage ovarian carcinomas distinguishes progression-free survival in patients and identifies candidate epigenetic markers

1 reference

https://pubmed.ncbi.nlm.nih.gov/20564122

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CpG Island Methylation of DNA Damage Response Genes in Advanced Ovarian Cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20564122

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Carboplatin hypersensitivity: a 6-h 12-step protocol effective in 35 desensitizations in patients with gynecological malignancies and mast cell/IgE-mediated reactions

1 reference

https://pubmed.ncbi.nlm.nih.gov/20564122

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized phase II study on the effects of 5-Aza-2'-deoxycytidine combined with either amsacrine or idarubicin in patients with relapsed acute leukemia: an EORTC Leukemia Cooperative Group phase II study (06893)

1 reference

https://pubmed.ncbi.nlm.nih.gov/20564122

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cancer stem cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/20564122

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CA125 in ovarian cancer: European Group on Tumor Markers guidelines for clinical use

1 reference

https://pubmed.ncbi.nlm.nih.gov/20564122

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Methylation of serum DNA is an independent prognostic marker in colorectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20564122

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cancer of the ovary

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25204

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.25204

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20564122%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20564122%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20564122%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34091420&oldid=2143833160"